ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · Real-Time Price · USD
5.90
+0.40 (7.27%)
Dec 5, 2025, 1:31 PM EST - Market open
ENDRA Life Sciences Market Cap
ENDRA Life Sciences has a market cap or net worth of $6.88 million as of December 5, 2025. Its market cap has increased by 190.39% in one year.
Market Cap
6.88M
Enterprise Value
6.48M
1-Year Change
190.39%
Ranking
Category
Stock Price
$5.90
Market Cap Chart
Since June 30, 2017, ENDRA Life Sciences's market cap has decreased from $15.15M to $6.88M, a decrease of -54.58%. That is a compound annual growth rate of -8.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2025 | 6.95M | 106.74% |
| Dec 31, 2024 | 3.36M | -81.25% |
| Dec 29, 2023 | 17.92M | 39.49% |
| Dec 30, 2022 | 12.85M | -55.92% |
| Dec 31, 2021 | 29.15M | 15.68% |
| Dec 31, 2020 | 25.20M | 100.27% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 936.68B |
| Johnson & Johnson | 494.92B |
| AbbVie | 396.55B |
| UnitedHealth Group | 293.98B |
| AstraZeneca | 282.37B |
| Novartis AG | 253.36B |
| Merck & Co. | 250.76B |
| Abbott Laboratories | 219.65B |